Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
Read More
FDA Accepts Priority Review for Linvoseltamab to Treat Adult Patients With R/R MM
February 22nd 2024Currently, the safety and efficacy of linvoseltamab in adult patients with relapsed or refractory multiple myeloma is being compared to elotuzumab, pomalidomide, and dexamethasone in a phase 3 clinical trial.
Read More
All Pharmacies Are Not the Same: Community Pharmacy Quality
Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Read More
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
Precision oncology represents an evolution in therapeutic practice.
Read More
Public Health Matters Video: The Significance of Language, Cultural Competency in Health Care
February 22nd 2024Tune into this episode of "Public Health Matters" to learn about the importance of cultural competence when addressing health care disparities and promoting health equity in diverse communities as well as special guest Dr. Jose Cucalon Calderon's advocacy work.
Watch